Extendicare Inc. (EXETF)
USD 7.0
(-0.71%)
USD 7.0
(-0.71%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 334.51 Million CAD | -12.88% |
| 2022 | 383.97 Million CAD | -28.48% |
| 2021 | 536.85 Million CAD | -4.91% |
| 2020 | 564.59 Million CAD | 1.49% |
| 2019 | 556.3 Million CAD | 5.17% |
| 2018 | 528.97 Million CAD | -1.32% |
| 2017 | 536.06 Million CAD | 6.45% |
| 2016 | 503.56 Million CAD | 10.9% |
| 2015 | 454.07 Million CAD | -5.2% |
| 2014 | 478.98 Million CAD | -58.88% |
| 2013 | 1.16 Billion CAD | 2.88% |
| 2012 | 1.13 Billion CAD | -0.19% |
| 2011 | 1.13 Billion CAD | -7.22% |
| 2010 | 1.22 Billion CAD | -0.92% |
| 2009 | 1.23 Billion CAD | -7.41% |
| 2008 | 1.33 Billion CAD | 24.36% |
| 2007 | 1.07 Billion CAD | 25.91% |
| 2006 | 851.18 Million CAD | 6.88% |
| 2005 | 796.39 Million CAD | 28.26% |
| 2004 | 620.9 Million CAD | -18.03% |
| 2003 | 757.5 Million CAD | -11.62% |
| 2002 | 857.13 Million CAD | 5.5% |
| 2001 | 812.42 Million CAD | -1.58% |
| 2000 | 825.44 Million CAD | -11.59% |
| 1999 | 933.68 Million CAD | -10.8% |
| 1998 | 1.04 Billion CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 326.26 Million CAD | -1.16% |
| 2024 Q1 | 330.08 Million CAD | -1.32% |
| 2023 Q2 | 399.97 Million CAD | 0.77% |
| 2023 Q4 | 334.51 Million CAD | -1.4% |
| 2023 Q1 | 396.91 Million CAD | 3.37% |
| 2023 FY | 334.51 Million CAD | -12.88% |
| 2023 Q3 | 339.27 Million CAD | -15.18% |
| 2022 Q4 | 383.97 Million CAD | 3.14% |
| 2022 FY | 383.97 Million CAD | -28.48% |
| 2022 Q1 | 367.01 Million CAD | -31.64% |
| 2022 Q3 | 372.27 Million CAD | -0.24% |
| 2022 Q2 | 373.18 Million CAD | 1.68% |
| 2021 Q2 | 551.15 Million CAD | -1.29% |
| 2021 Q3 | 545.37 Million CAD | -1.05% |
| 2021 Q4 | 536.85 Million CAD | -1.56% |
| 2021 Q1 | 558.37 Million CAD | -1.1% |
| 2021 FY | 536.85 Million CAD | -4.91% |
| 2020 Q4 | 564.59 Million CAD | -1.16% |
| 2020 FY | 564.59 Million CAD | 1.49% |
| 2020 Q3 | 571.22 Million CAD | -1.06% |
| 2020 Q2 | 577.33 Million CAD | 4.14% |
| 2020 Q1 | 554.37 Million CAD | -0.35% |
| 2019 Q1 | 532.79 Million CAD | 0.72% |
| 2019 FY | 556.3 Million CAD | 5.17% |
| 2019 Q2 | 558.34 Million CAD | 4.79% |
| 2019 Q3 | 558.92 Million CAD | 0.1% |
| 2019 Q4 | 556.3 Million CAD | -0.47% |
| 2018 Q1 | 533.68 Million CAD | -0.45% |
| 2018 Q3 | 523.85 Million CAD | 0.9% |
| 2018 Q4 | 528.97 Million CAD | 0.98% |
| 2018 FY | 528.97 Million CAD | -1.32% |
| 2018 Q2 | 519.18 Million CAD | -2.72% |
| 2017 Q2 | 533.8 Million CAD | 6.5% |
| 2017 Q4 | 536.06 Million CAD | 0.89% |
| 2017 FY | 536.06 Million CAD | 6.45% |
| 2017 Q1 | 501.24 Million CAD | -0.46% |
| 2017 Q3 | 531.35 Million CAD | -0.46% |
| 2016 Q2 | 446.51 Million CAD | -0.64% |
| 2016 FY | 503.56 Million CAD | 10.9% |
| 2016 Q4 | 503.56 Million CAD | 0.67% |
| 2016 Q3 | 500.23 Million CAD | 12.03% |
| 2016 Q1 | 449.36 Million CAD | -1.04% |
| 2015 Q1 | 466.91 Million CAD | -2.52% |
| 2015 Q4 | 454.07 Million CAD | -0.98% |
| 2015 Q3 | 458.58 Million CAD | -15.02% |
| 2015 Q2 | 539.63 Million CAD | 15.57% |
| 2015 FY | 454.07 Million CAD | -5.2% |
| 2014 Q1 | 1.18 Billion CAD | 1.32% |
| 2014 FY | 478.98 Million CAD | -58.88% |
| 2014 Q3 | 1.19 Billion CAD | 5.04% |
| 2014 Q4 | 478.98 Million CAD | -60.08% |
| 2014 Q2 | 1.14 Billion CAD | -3.22% |
| 2013 Q1 | 1.14 Billion CAD | 1.01% |
| 2013 Q3 | 1.16 Billion CAD | -0.62% |
| 2013 Q4 | 1.16 Billion CAD | 0.34% |
| 2013 FY | 1.16 Billion CAD | 2.88% |
| 2013 Q2 | 1.16 Billion CAD | 2.14% |
| 2012 Q1 | 1.1 Billion CAD | -2.32% |
| 2012 Q3 | 1.2 Billion CAD | 7.81% |
| 2012 Q4 | 1.13 Billion CAD | -5.7% |
| 2012 FY | 1.13 Billion CAD | -0.19% |
| 2012 Q2 | 1.11 Billion CAD | 0.5% |
| 2011 Q3 | 1.24 Billion CAD | -1.92% |
| 2011 Q4 | 1.13 Billion CAD | -8.95% |
| 2011 FY | 1.13 Billion CAD | -7.22% |
| 2011 Q1 | 1.23 Billion CAD | 0.97% |
| 2011 Q2 | 1.27 Billion CAD | 2.9% |
| 2010 Q4 | 1.22 Billion CAD | -0.04% |
| 2010 Q3 | 1.22 Billion CAD | -2.69% |
| 2010 Q1 | 1.21 Billion CAD | -1.27% |
| 2010 Q2 | 1.25 Billion CAD | 3.17% |
| 2010 FY | 1.22 Billion CAD | -0.92% |
| 2009 Q3 | 1.24 Billion CAD | -4.19% |
| 2009 Q1 | 1.35 Billion CAD | 2.0% |
| 2009 Q2 | 1.29 Billion CAD | -4.79% |
| 2009 Q4 | 1.23 Billion CAD | -0.5% |
| 2009 FY | 1.23 Billion CAD | -7.41% |
| 2008 Q4 | 1.33 Billion CAD | 10.12% |
| 2008 Q1 | 1.09 Billion CAD | 2.58% |
| 2008 Q2 | 1.17 Billion CAD | 6.47% |
| 2008 Q3 | 1.21 Billion CAD | 3.4% |
| 2008 FY | 1.33 Billion CAD | 24.36% |
| 2007 FY | 1.07 Billion CAD | 25.91% |
| 2007 Q4 | 1.07 Billion CAD | 11.42% |
| 2007 Q3 | 961.86 Million CAD | -3.75% |
| 2007 Q2 | 999.28 Million CAD | 2.85% |
| 2007 Q1 | 971.56 Million CAD | 14.14% |
| 2006 Q2 | 788.9 Million CAD | -4.0% |
| 2006 Q3 | 838.42 Million CAD | 6.28% |
| 2006 FY | 851.18 Million CAD | 6.88% |
| 2006 Q1 | 821.75 Million CAD | 3.18% |
| 2006 Q4 | 851.18 Million CAD | 1.52% |
| 2005 Q3 | 824.89 Million CAD | -5.32% |
| 2005 FY | 796.39 Million CAD | 28.26% |
| 2005 Q1 | 873.67 Million CAD | 40.71% |
| 2005 Q2 | 871.24 Million CAD | -0.28% |
| 2005 Q4 | 796.39 Million CAD | -3.46% |
| 2004 FY | 620.9 Million CAD | -18.03% |
| 2004 Q4 | 620.9 Million CAD | -2.91% |
| 2004 Q3 | 639.54 Million CAD | -5.63% |
| 2004 Q2 | 677.7 Million CAD | -8.2% |
| 2004 Q1 | 738.26 Million CAD | -2.54% |
| 2003 Q4 | 757.5 Million CAD | -4.39% |
| 2003 FY | 757.5 Million CAD | -11.62% |
| 2003 Q1 | 817.31 Million CAD | 0.0% |
| 2003 Q2 | 783.36 Million CAD | -4.15% |
| 2003 Q3 | 792.29 Million CAD | 1.14% |
| 2002 FY | 857.13 Million CAD | 5.5% |
| 2001 FY | 812.42 Million CAD | -1.58% |
| 2000 FY | 825.44 Million CAD | -11.59% |
| 1999 FY | 933.68 Million CAD | -10.8% |
| 1998 FY | 1.04 Billion CAD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| The Amacore Group, Inc. | 2.85 Million USD | -11627.121% |
| Arem Pacific Corporation | 224.41 Thousand USD | -148960.009% |
| Assisted 4 Living, Inc. | 43.05 Thousand USD | -776832.367% |
| BioCorRx Inc. | 5.63 Million USD | -5836.685% |
| Bionik Laboratories Corp. | 2.41 Million USD | -13767.046% |
| Banyan Corp. | 3.65 Million USD | -9041.195% |
| Clearday, Inc. | 45.06 Million USD | -642.319% |
| Dental Patient Care America, Inc. | 27 Thousand USD | -1238802.263% |
| Quantum Medical Transport, Inc. | 1097.80 USD | -30471388.431% |
| Empower Clinics Inc. | 2.49 Million USD | -13323.644% |
| First Choice Healthcare Solutions, Inc. | 23.24 Million USD | -1339.249% |
| Selectis Health, Inc. | 37.24 Million USD | -798.113% |
| Ethema Health Corporation | 14.58 Million USD | -2193.86% |
| HealthLynked Corp. | 1.97 Million USD | -16848.314% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 14.45 Million USD | -2214.581% |
| JRSIS Health Care Corporation | 1.02 Million USD | -32378.953% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 116.21 Million USD | -187.851% |
| MedSmart Group Inc. | 788.04 Thousand USD | -42348.899% |
| North America Frac Sand, Inc. | 275 Thousand USD | -121542.182% |
| Nova Leap Health Corp. | 208.23 Thousand USD | -160540.418% |
| Nexteligent Holdings, Inc. | 1.88 Million USD | -17688.314% |
| PAO Group, Inc. | 639.95 Thousand USD | -52172.209% |
| Primemd Inc. | 7.13 Million USD | -4589.081% |
| Raffles Medical Group Ltd | 65.87 Million USD | -407.796% |
| Ryman Healthcare Limited | 1.53 Billion USD | 78.215% |
| Stem Cell Authority, Ltd. | - USD | -Infinity% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 1.34 Million USD | -24708.954% |
| Mycotopia Therapies, Inc. | 1.09 Million USD | -30571.223% |
| U.S. NeuroSurgical Holdings, Inc. | 85 Thousand USD | -393448.235% |
| Veltex Corporation | 2.18 Million USD | -15210.624% |
| World Financial Holding Group | 98.4 Thousand USD | -339838.011% |
| Xcelerate Inc. | 1.42 Million USD | -23444.316% |